Rallis Crop Care business include Crop Protection and Crop Nutrition solutions. Our Crop Protection portfolio of active ingredients, bulk and branded formulations covers herbicides, insecticides and fungicides and caters to domestic and export markets. Our Crop Nutrition portfolio, which is largely focussed on the domestic market, consists of biostimulants, biofertilisers, biopesticides, organic fertilisers, water-soluble fertilisers as well as micro and secondary nutrients.
Rallis is known for its long experience in serving Rural Markets and strong bonds with the farming community across the country. Leveraging Tata and Rallis brand equities and the wide distribution network, the Company is continuing to meet the changing needs of our customers by providing Crop Care solutions.
Remunerative crop prices and encouraging water levels are expected to lead to positive farm sentiments and higher demand for crop inputs despite the forecasted El Niño effect in 2023. Our new product launches and enhanced retailer footprint would drive our growth.
Rallis’ production capacities and process development capabilities are quite significant and complemented by International EHS standards and strict quality parameters to meet the global requirements.
Rallis also has established strategic alliances across the globe and is a preferred partner for contract manufacturing.
Revenue growth will be driven primarily by volume increases for key technicals introduction of new products, wider market access and improvement in formulation sales.
Dahej, SEZ
FY 2022-23 was a mixed season for India’s seed industry. Strong commodity prices across crops maintained the rising demand for seeds. However, reduced demand for Hybrid Paddy and the presence of illegal cotton led to increased sales returns in Hybrid Paddy and Cotton in a few markets. Provision for inventory and impairment of intangible assets further impacted profitability for the year.
Sustainable and profitable growth remains our key priority. Improving our gross margins and optimising fixed costs will remain a strategic and operational priority to create a positive impact on the bottom line.
Product differentiation activity
We made good progress in FY 2022-23 in terms of new launches, demand generation and trade engagement. Our growth momentum is expected to improve with competitive product launches in the next few years.
A Glimpse of Our Branding Journey